Secondary prevention after myocardial infarction: Role of antiplatelet therapy and lipid lowering drugs;Prevention secondaire de l'infarctus du myocarde; place des antiagregants plaquettaires et des hypolipemiants

Archives des Maladies du Coeur et des Vaisseaux

Volumn 89, Issue SPEC. ISS. 3, 1996, Pages 39-41

  Aumont, M C ^a   Seknadji, P ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COUMARIN DERIVATIVE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; SIMVASTATIN; SULFINPYRAZONE; TICLOPIDINE; WARFARIN; DRUG DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; MEVINOLIN;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; DRUG EFFECT; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; MORTALITY; ARTICLE; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; META ANALYSIS; RISK FACTOR;

ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; ASPIRIN; CORONARY DISEASE; COST-BENEFIT ANALYSIS; GEMFIBROZIL; HUMANS; LOVASTATIN; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SIMVASTATIN;

EID: 0029747246     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction. Lancet 1988 ; ii : 349-60.
2. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I : prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1988 ; 308 : 81-106.
3. Brochier ML. Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. Eur Heart J 1993 ; 14 : 951-7.
4. Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992 ; 20 : 1549-55.
5. Alhaddad IA, Tkaczevski L, Siddiqui F, Mir R, Brown EJ. Aspirin enhances the benefits of late reperfusion on infarct shape. Circulation 1995 ; 91 : 2819-23.
6. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit : a new look at old data. Circulation 1995 ; 91 : 2274-82.
7. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease. Lancet 1994 ; 344 : 1383-9.
8. Levine GN, Keaney JF, Vita JA. Cholesterol reduction in cardiovascular disease. N Engl J Med 1995 ; 332 : 512-21.
9. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995 ; 332 : 488-93.
10. Treasure CB, Klein JL, Weintraub WS et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995 ; 332 : 481-7.